SEC Form 4 · accession 0001862900-26-000009
Nuvalent, Inc. · NUVL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James Richard Porter
Officer — President and CEO · Director
Period of report
Jun 8, 2026
Accepted (ET)
Jun 10, 2026 · 4:30 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001861560
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Jun 8, 2026 | M | 30,000 | $18.93 | A | 354,879 | D | |
| Class A Common StockF2 | Jun 8, 2026 | S | 12,495 | $87.97 | D | 342,384 | D | |
| Class A Common StockF3 | Jun 8, 2026 | S | 14,469 | $88.79 | D | 327,915 | D | |
| Class A Common StockF4 | Jun 8, 2026 | S | 3,036 | $89.63 | D | 324,879 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F5 | $18.93 | Jun 8, 2026 | M | 30,000 | D | — | Jan 4, 2032 | Class A Common Stock | 30,000 | 148,686 | D |
Explanation of responses
- F1These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 4, 2025.
- F2The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $87.35 to $88.34, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, Nuvalent, Inc. or any security holder of Nuvalent, Inc., upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (4) of this Form 4.
- F3The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $88.35 to $89.34, inclusive.
- F4The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.35 to $90.17, inclusive.
- F5The shares underlying this option are fully vested.